European Union - English - EMA (European Medicines Agency)

laboratorios hipra s.a. - inactivated bordetella bronchiseptica, strain 833cer / recombinant type-d pasteurella-multocida toxin (pmtr) - immunologicals - pigs (gilts and sows) - for the passive protection of piglets via colostrum after active immunisation of sows and gilts to reduce the clinical signs and lesions of progressive and non-progressive atrophic rhinitis, as well as to reduce weight loss associated with bordetella-bronchiseptica and pasteurella-multocida infections during the fattening period. challenge studies have demonstrated that passive immunity lasts until piglets are six weeks of age while in clinical field trials, the beneficial effects of vaccination (reduction in nasal lesion score and weight loss) are observed until slaughter.

European Union - English - EMA (European Medicines Agency)

laboratorios hipra s.a. - escherichia coli j5 inactivated, staphylococcus aureus (cp8) strain sp 140 inactivated, expressing slime-associated antigenic complex - immunologicals for bovidae - cattle (cows and heifers) - for herd immunisation of healthy cows and heifers, in dairy cattle herds with recurring mastitis problems, to reduce the incidence of sub-clinical mastitis and the incidence and the severity of the clinical signs of clinical mastitis caused by staphylococcus aureus, coliforms and coagulase-negative staphylococci.the full immunisation scheme induces immunity from approximately day 13 after the first injection until approximately day 78 after the third injection (equivalent to 130 days post-parturition).

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

laboratorios hipra s.a. - florfenicol - parenteral liquid/solution/suspension - florfenicol antibiotic active 300.0 mg/ml - antibiotic & related

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

laboratorios león farma s.a. - ethinylestradiol 3,474 mg; etonogestrel 11 mg - vaginal delivery system - 0,120 mg/24 h - 0,015 mg/24 h - etonogestrel 11 mg; ethinylestradiol 3.474 mg - vaginal ring with progestogen and estrogen

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

laboratorios liconsa s.a. - tapentadol tartrate 167,81 mg - eq. tapentadol 100 mg - prolonged-release tablet - tapentadol

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

laboratorios liconsa s.a. - tapentadol tartrate 251,715 mg - eq. tapentadol 150 mg - prolonged-release tablet - tapentadol

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

laboratorios liconsa s.a. - tapentadol tartrate 335,62 mg - eq. tapentadol 200 mg - prolonged-release tablet - tapentadol

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

laboratorios liconsa s.a. - tapentadol tartrate 41,9525 mg - eq. tapentadol 25 mg - prolonged-release tablet - tapentadol

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

laboratorios liconsa s.a. - tapentadol tartrate 419,525 mg - eq. tapentadol 250 mg - prolonged-release tablet - tapentadol

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

laboratorios liconsa s.a. - tapentadol tartrate 83,905 mg - eq. tapentadol 50 mg - prolonged-release tablet - tapentadol